Top

Journal of Assisted Reproduction and Genetics

Published in:

01-11-2013 | Assisted Reproduction Technologies

Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve

Authors: Dan Nayot, Jin Tae Chung, Weon-Young Son, Assangla Ao, Mark Hughes, Michael H. Dahan

Published in: Journal of Assisted Reproduction and Genetics | Issue 11/2013

Abstract

Purpose

To present a live birth resulting from serial vitrification of embryos and pre-implantation genetic diagnosis (PGD).

Methods

A 31-year-old with primary infertility, fragile-X premutation, and decreased ovarian reserve (DOR) (baseline FSH level 33 IU/L), presented after failing to stimulate to follicle diameters >10 mm with three cycles of invitro fertilization (IVF). After counseling, the couple opted for serial in-vitro maturation (IVM), embryo vitrification, and genetic testing using array comparative genomic hybridization (aCGH) and PGD. Embryos were vitrified 2 days after intra-cytoplasmic sperm injection (ICSI). Thawed embryos were biopsied on day-three and transferred on day-five.

Results

The couple underwent 20 cycles of assisted reproductive technology. A total of 23 in-vivo mature and five immature oocytes were retrieved, of which one matured in-vitro. Of 24 embryos, 17/24 (71 %) developed to day two and 11/24 (46 %) survived to blastocyst stage with a biopsy result available. Four blastocysts had normal PGD and aCGH results. Both single embryo transfers resulted in a successful implantation, one a blighted ovum and the other in a live birth.

Conclusions

Young patients with DOR have potential for live birth as long as oocytes can be obtained and embryos created. Serial vitrification may be the mechanism of choice in these patients when PGD is needed.

Aanesen A, Nygren KG, Nylund L. Modified natural cycle IVF and mild IVF: a 10 year Swedish experience. Reprod Biomed Online. 2010;20(1):156–62.PubMedCrossRef

Ao A, Jin S, Rao D, Son WY, Chian RC, Tan SL. First successful pregnancy outcome after preimplantation genetic diagnosis for aneuploidy screening in embryos generated from natural-cycle in vitro fertilization combined with an in vitro maturation procedure. Fertil Steril. 2006;85(5):1510-e9–11.CrossRef

Ao A, Zhang XY, Tan SL. First successful pregnancy following PGD for chromosome translocation on embryos generated from in-vitro matured oocytes: a case report. Reprod Biomed Online. 2011;22(4):371–5.PubMedCrossRef

Buckett WM, Chian RC, Dean NL, Sylvestre C, Holzer HE, et al. Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection. Fertil Steril. 2008;90(3):546–50.PubMedCrossRef

Fridén B, Hreinsson J, Hovatta O. Birth of a healthy infant after in vitro oocyte maturation and ICSI in a woman with diminished ovarian response: case report. Hum Reprod. 2005;20(9):2556–8.PubMedCrossRef

Gallagher A, Hallahan B. Fragile X-associated disorders: a clinical overview. J Neurol. 2012;259(3):401–13.PubMedCrossRef

Gleicher N, Barad DH. The FMR1 gene as regulator of ovarian recruitment and ovarian reserve. Obstet Gynecol Surv. 2010;65(8):523–30.PubMedCrossRef

Gleicher N, Kim A, Weghofer A, Barad DH. Differences in ovarian aging patterns between races are associated with ovarian genotypes and sub-genotypes of the FMR1 gene. Reprod Biol Endocrinol. 2012;10:77.PubMedCrossRef

Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol. 2011;9:23.PubMedCrossRef

10.

Li J, Xu Y, Zhou G, Guo J, Xin N. Natural cycle IVF/IVM may be more desirable for poor responder patients after failure of stimulated cycles. J Assist Reprod Genet. 2011;28(9):791–5.PubMedCrossRef

11.

Liu J, Lu G, Qian Y, Mao Y, Ding W. Pregnancies and births achieved from in vitro matured oocytes retrieved from poor responders undergoing stimulation in in vitro fertilization cycles. Fertil Steril. 2003;80(2):447–9.PubMedCrossRef

12.

Lukaszuk K, Kunicki M, Liss J, Lukaszuk M, Jakiel G. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 2013;168(2):173–7.

13.

Nolin SL, Brown WT, Glicksman A, Houck Jr GE, Gargano AD, et al. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet. 2003;72(2):454–64.PubMedCrossRef

14.

Requena A, Bronet F, Guillén A, Agudo D, Bou C, et al. The impact of in-vitro maturation of oocytes on aneuploidy rate. Reprod Biomed Online. 2009;18(6):777–83.PubMedCrossRef

15.

Schoolcraft WB, Fragouli E, Stevens J, Munne S, Katz-Jaffe MG, et al. Clinical application of comprehensive chromosomal screening at the blastocyst stage. Fertil Steril. 2010;94(5):1700–6.PubMedCrossRef

16.

Son WY, Chung JT, Chian RC, Herrero B, Demirtas E, Elizur S, et al. A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles. Hum Reprod. 2008;23(9):2010–6.PubMedCrossRef

17.

Son WY, Chung JT, Dahan M, Reinblatt S, Tan SL, et al. Comparison of fertilization and embryonic development in sibling in-vivo matured oocytes retrieved from different sizes follicles from in vitro maturation cycles. J Assist Reprod Genet. 2011;28(6):539–44.PubMedCrossRef

18.

Son WY, Chung JT, Das M, Buckett W, Demirtas E, Holzer H. Fertilization, embryo development, and clinical outcome of immature oocytes obtained from natural cycle in vitro fertilization. J Assist Reprod Genet. 2013;30(1):43–7.PubMedCrossRef

19.

Son WY, Chung JT, Gidoni Y, Holzer H, Levin D, et al. Comparison of survival rate of cleavage stage embryos produced from in vitro maturation cycles after slow freezing and after vitrification. Fertil Steril. 2009;92(3):956–8.PubMedCrossRef

20.

Son WY, Yoon SH, Lim JH. Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS. Reprod Biomed Online. 2006;13(3):340–8.PubMedCrossRef

21.

Van Esch H. The Fragile X premutation: new insights and clinical consequences. Eur J Med Genet. 2006;49(1):1–8.PubMedCrossRef

22.

Yakut T, Karkucak M, Sher G, Keskintepe L. Comparison of aneuploidy frequencies between in vitro matured and unstimulated cycles oocytes by metaphase comparative genomic hybridization (mCGH). Mol Biol Rep. 2012;39(5):6187–91.PubMedCrossRef

23.

Zhang XY, Ata B, Son WY, Buckett WM, Tan SL, et al. Chromosome abnormality rates in human embryos obtained from in-vitro maturation and IVF treatment cycles. Reprod Biomed Online. 2010;21(4):552–9.PubMedCrossRef

24.

Zhang L, Yilmaz A, Chian RC, Son WY, Zhang XY, Kong D, et al. Reliable preimplantation genetic diagnosis in thawed human embryos vitrified at cleavage stages without biopsy. J Assist Reprod Genet. 2011;28(7):597–602.PubMedCrossRef

Title: Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve
Authors: Dan Nayot
Jin Tae Chung
Weon-Young Son
Assangla Ao
Mark Hughes
Michael H. Dahan
Publication date: 01-11-2013
Publisher: Springer US
Published in: Journal of Assisted Reproduction and Genetics / Issue 11/2013
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-013-0079-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2013

Serum markers of ovarian reserve and ovarian histology in adult mice treated with cyclophosphamide in pre-pubertal age

A prospective randomized study to evaluate the effect of hyaluronic acid sperm selection on the intracytoplasmic sperm injection outcome of patients with unexplained infertility having normal semen parameters

In vitro development of human primordial follicles to preantral stage after vitrification

Comment on: “Clomiphene Citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial.” by Ghanem et al.

Assisted reproduction counseling in women aged 40 and above: a cohort study

Human chorionic gonadotropin levels are equally predictive for pregnancy outcome after fresh and vitrified-warmed blastocyst transfer